Invasive Mold Infections After Chimeric Antigen Receptor-Modified T-Cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis
- PMID: 31756246
- DOI: 10.1093/cid/ciz1127
Invasive Mold Infections After Chimeric Antigen Receptor-Modified T-Cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis
Abstract
Data on invasive mold infections (IMIs) after chimeric antigen receptor-modified T-cell (CAR-T-cell) therapy are limited. We describe 2 patients with post-CAR-T-cell IMI (Fusarium, Mucorales) and review the published literature. We propose strategies to prevent IMIs in patients, based on the IMI rate and presence of neutropenia or steroid use.
Keywords: CAR-T-cell; fungal infections; neutropenia; prophylaxis; steroids.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Reply to Lewis and Kontoyiannis.Clin Infect Dis. 2020 Oct 23;71(7):1803-1804. doi: 10.1093/cid/ciaa032. Clin Infect Dis. 2020. PMID: 31926004 No abstract available.
-
Chimeric Antigen Receptor T-cell Immunotherapy and Need for Prophylaxis for Invasive Mold Infections.Clin Infect Dis. 2020 Oct 23;71(7):1802-1803. doi: 10.1093/cid/ciaa031. Clin Infect Dis. 2020. PMID: 31927567 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources